[Form 4] Omada Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Steven L. Cook, Chief Financial Officer of Omada Health, Inc. (OMDA), reported a sale of shares on 09/05/2025. The Form 4 shows a disposition of 2,006 shares of common stock at a price of $24.28 per share, leaving Mr. Cook with 63,783 shares owned directly after the transaction. The filing was signed by an attorney-in-fact on 09/09/2025.

Positive

• Filing includes complete transaction details (date, code, shares, price, resulting ownership)
• Reporting person identified with role (Chief Financial Officer) and ownership form (Direct)

Negative

• Insider disposed of shares (2,006 shares sold), which could be viewed negatively by some investors
• No additional context provided about the reason for the sale (e.g., personal liquidity, diversification, or 10b5-1 plan)

Insights

Financial Analyst

TL;DR: Routine insider sale reported; no additional financial context provided to assess material impact.

The Form 4 documents a single non-derivative sale (Code F) of 2,006 common shares by the CFO at $24.28, leaving 63,783 shares held directly. Without accompanying disclosures about planned transfers, hedging, or a rule 10b5-1 plan, this record is a straightforward disclosure of a completed sale and does not by itself indicate a change in company fundamentals or guidance.

Corporate Governance Expert

TL;DR: Filing appears compliant and timely; transaction was signed by an attorney-in-fact.

The Form 4 is completed with required fields: reporting person identity, relationship (Officer, CFO), transaction date, code, number of shares disposed, price, and resulting beneficial ownership. Signature executed by an attorney-in-fact is noted. This is a routine disclosure under Section 16 and reflects adherence to reporting obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cook Steven L.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2025		F		2,006	D	$24.28	63,783	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nathan Salha, as Attorney-in-Fact for Steven L. Cook	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Omada Health (OMDA) insider Steven L. Cook report on the Form 4?

The Form 4 reports a sale of 2,006 shares of Omada Health common stock on 09/05/2025 at $24.28 per share, leaving 63,783 shares owned directly.

What transaction code is listed on the OMDA Form 4 and what does it mean?

The Form 4 lists Transaction Code F, indicating a disposition of securities (the filing shows a sale of shares).

Who signed the Form 4 for Steven L. Cook?

The Form 4 was signed by Nathan Salha, as Attorney-in-Fact for Steven L. Cook on 09/09/2025.

How many shares does Steven L. Cook own after the reported transaction?

After the reported sale, Steven L. Cook beneficially owns 63,783 shares of Omada Health common stock.

Does the Form 4 indicate whether the sale was part of a 10b5-1 plan?

The filing does not indicate that the transaction was made pursuant to a 10b5-1 plan; no such plan is referenced in the Form 4 content provided.